瀘州老窖(000568.SZ):決定與老窖集團、能投集團共設科創公司
格隆匯2月28日丨瀘州老窖(000568.SZ)公佈,公司第十屆董事會十三次會議決議,審議通過了《關於參與投資設立瀘州老窖博士後工作站科創有限公司暨關聯交易的議案》。
公司決定與控股股東瀘州老窖集團有限責任公司(“老窖集團”)以及瀘州能源投資有限公司(“能投集團”)共同投資設立瀘州老窖博士後工作站科創有限公司(“科創公司”,暫定名,以實際工商註冊為準)。科創公司註冊資本10000萬元,其中公司以現金方式出資4000萬元,佔總股本的40%;老窖集團出資5100萬元,佔總股本的51%;能投集團出資900萬元,佔總股本的9%。科創公司成立後可進一步提升公司整體科技創新水平和質量技術實力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.